Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191)).
J Infect. 2022 Apr;84(4):e10-e12. doi: 10.1016/j.jinf.2022.01.035. Epub 2022 Feb 1.
J Infect. 2022.
PMID: 35120973
No abstract available.
Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.
Liang XS, Li CZ, Zhou Y, Yin W, Liu YY, Fan WH.
Liang XS, et al. Among authors: fan wh.
World J Gastroenterol. 2014 Jul 14;20(26):8558-71. doi: 10.3748/wjg.v20.i26.8558.
World J Gastroenterol. 2014.
PMID: 25024610
Free PMC article.
Item in Clipboard
Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS.
Li CZ, et al. Among authors: fan wh.
World J Gastroenterol. 2014 Jul 28;20(28):9486-96. doi: 10.3748/wjg.v20.i28.9486.
World J Gastroenterol. 2014.
PMID: 25071343
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite